Stock Analysis
- United States
- /
- Healthtech
- /
- NYSE:VEEV
Veeva Systems Inc. (NYSE:VEEV) Just Released Its Yearly Earnings: Here's What Analysts Think
It's been a pretty great week for Veeva Systems Inc. (NYSE:VEEV) shareholders, with its shares surging 10% to US$247 in the week since its latest yearly results. The result was positive overall - although revenues of US$2.7b were in line with what the analysts predicted, Veeva Systems surprised by delivering a statutory profit of US$4.32 per share, modestly greater than expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
See our latest analysis for Veeva Systems
Taking into account the latest results, the most recent consensus for Veeva Systems from 28 analysts is for revenues of US$3.05b in 2026. If met, it would imply a decent 11% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to grow 11% to US$4.90. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$3.06b and earnings per share (EPS) of US$4.69 in 2026. So the consensus seems to have become somewhat more optimistic on Veeva Systems' earnings potential following these results.
There's been no major changes to the consensus price target of US$265, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Veeva Systems analyst has a price target of US$307 per share, while the most pessimistic values it at US$201. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Veeva Systems shareholders.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Veeva Systems' past performance and to peers in the same industry. It's pretty clear that there is an expectation that Veeva Systems' revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 11% growth on an annualised basis. This is compared to a historical growth rate of 16% over the past five years. Compare this to the 69 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 9.7% per year. Factoring in the forecast slowdown in growth, it looks like Veeva Systems is forecast to grow at about the same rate as the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Veeva Systems following these results. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. The consensus price target held steady at US$265, with the latest estimates not enough to have an impact on their price targets.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Veeva Systems going out to 2028, and you can see them free on our platform here.
Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:VEEV
Veeva Systems
Provides cloud-based software for the life sciences industry.